Swiss National Bank Has $12.67 Million Holdings in Steris PLC (STE)
Swiss National Bank boosted its stake in shares of Steris PLC (NYSE:STE) by 1.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 144,855 shares of the medical equipment provider’s stock after buying an additional 2,600 shares during the period. Swiss National Bank owned approximately 0.17% of Steris worth $12,670,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Jaffetilchin Investment Partners LLC bought a new stake in shares of Steris in the 4th quarter worth $409,000. The Manufacturers Life Insurance Company grew its holdings in shares of Steris by 1.6% in the second quarter. The Manufacturers Life Insurance Company now owns 122,520 shares of the medical equipment provider’s stock worth $9,986,000 after acquiring an additional 1,963 shares during the period. Prudential Financial Inc. grew its holdings in shares of Steris by 14.4% in the third quarter. Prudential Financial Inc. now owns 192,686 shares of the medical equipment provider’s stock worth $17,034,000 after acquiring an additional 24,220 shares during the period. Canada Pension Plan Investment Board grew its holdings in shares of Steris by 13.2% in the third quarter. Canada Pension Plan Investment Board now owns 54,100 shares of the medical equipment provider’s stock worth $4,782,000 after acquiring an additional 6,300 shares during the period. Finally, Keybank National Association OH bought a new stake in shares of Steris in the third quarter worth $554,000. 89.40% of the stock is owned by institutional investors.
Shares of Steris PLC (NYSE:STE) opened at $94.91 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.22 and a current ratio of 2.82. Steris PLC has a 52 week low of $67.55 and a 52 week high of $96.43. The firm has a market capitalization of $8,050.00, a P/E ratio of 33.42 and a beta of 1.17.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 28th. Stockholders of record on Wednesday, February 28th will be paid a dividend of $0.31 per share. This is a boost from Steris’s previous quarterly dividend of $0.21. The ex-dividend date is Tuesday, February 27th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.31%. Steris’s dividend payout ratio is currently 43.66%.
STE has been the topic of several analyst reports. Zacks Investment Research downgraded Steris from a “buy” rating to a “hold” rating in a research report on Wednesday, January 24th. Raymond James Financial restated a “market perform” rating and issued a $100.00 price objective on shares of Steris in a research report on Wednesday, January 3rd. Northcoast Research set a $102.00 price objective on Steris and gave the company a “buy” rating in a research report on Thursday, February 8th. Finally, KeyCorp restated a “buy” rating and issued a $103.00 price objective on shares of Steris in a research report on Thursday, February 8th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Steris presently has an average rating of “Buy” and a consensus price target of $84.80.
In related news, Director Richard Martin Steeves sold 58,953 shares of the business’s stock in a transaction that occurred on Monday, March 5th. The stock was sold at an average price of $91.00, for a total value of $5,364,723.00. Following the completion of the sale, the director now owns 9,362 shares in the company, valued at $851,942. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, March 12th. The shares were sold at an average price of $95.50, for a total value of $955,000.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 78,415 shares of company stock worth $7,178,536. Insiders own 2.55% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This piece was published by Marea Informative and is the sole property of of Marea Informative. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://www.mareainformativa.com/2018/03/15/swiss-national-bank-raises-position-in-steris-plc-ste-updated-updated-updated.html.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.